Molecular monitoring of alloimmune-mediated injury in kidney transplant patients

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 6, 2014, Pages 625-630

  Traitanon, Opas ^a   Poggio, Emilio D ^b   Fairchild, Robert L ^b,c  

^a THAMMASAT UNIVERSITY   (Thailand)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney transplantation; Microarray; microRNA; Molecular monitoring; mRNA

Indexed keywords

MICRORNA; MOLECULAR MARKER; ALLOANTIBODY; GENETIC MARKER; MESSENGER RNA;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; IMMUNE INJURY; KIDNEY GRAFT; KIDNEY INJURY; KIDNEY PARENCHYMA; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR MONITORING; PATIENT MONITORING; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REVIEW; URINALYSIS; ACUTE DISEASE; ADVERSE EFFECTS; GENETIC MARKER; GENETICS; GRAFT REJECTION; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE; PROCEDURES; TREATMENT OUTCOME;

ACUTE DISEASE; GENETIC MARKERS; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 84927595587     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000064     Document Type: Review

References (35)

1. Sijpkens YW, Doxiadis II, Mallat MJ, et al. Early versus late acute rejection episodes in renal transplantation. Transplantation 2003; 75:204-208.
2. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9:2520-2531.
3. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9:527-535.
4. Sigdel TK, Sarwal MM. The proteogenomic path towards biomarker discovery. Pediatr Transplant 2008; 12:737-747.
5. Mueller TF, Mas VR. Microarray applications in nephrology with special focus on transplantation. J Nephrol 2012; 25:589-602.
6. Consortium M, Shi L, Reid LH, et al. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24:1151-1161.
7. Reeve J, Sellares J, Mengel M, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013; 13:645-655.
8. Sellares J, Reeve J, Loupy A, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013; 13:971-983.
9. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8:753-760.
10. Solez K, Racusen LC. The Banff classification revisited. Kidney Int 2013; 83:201-206.
11. Haas M. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant 2014; 19:315-322.
12. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14:272-283.
13. Mueller TF, Reeve J, Jhangri GS, et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008; 8:78-85.
14. Kreepala C, Famulski KS, Chang J, Halloran PF. Comparing molecular assessment of implantation biopsies with histologic and demographic risk assessment. Am J Transplant 2013; 13:415-426.
15. Khatri P, Roedder S, Kimura N, et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 2013; 210:2205-2221.
16. Halloran PF, Pereira AB, Chang J, et al. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am J Transplant 2013; 13:2352-2363.
17. Halloran PF, Pereira AB, Chang J, et al. Microarray diagnosis of antibodymediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant 2013; 13:2865-2874.
18. Loupy A, Lefaucheur C, Vernerey D, et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 2014. [Epub ahead of print]
19. Suthanthiran M, Schwartz JE, Ding R, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 2013; 369:20-31.
20. Matignon M, Ding R, Dadhania DM, et al. Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol 2014; 25:1586-1597.
21. Hricik DE, Nickerson P, Formica RN, et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 2013; 13:2634-2644.
22. Li L, Khatri P, Sigdel TK, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 2012; 12:2710-2718.
23. Kurian SM, Williams AN, Gelbart T, et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant 2014; 14:1164-1172.
24. Danger R, Paul C, Giral M, et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibodymediated rejection. PLoS One 2013; 8:e60702.
25. Maluf DG, Dumur CI, Suh JL, et al. The urine microRNA profile may help monitor posttransplant renal graft function. Kidney Int 2014; 85:439-449.
26. Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010; 15:35-41.
27. Lee JR, Muthukumar T, Dadhania D, et al. Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev 2014; 258:218-240.
28. Keslar KS, Lin M, Zmijewska AA, et al. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. Am J Transplant 2013; 13:1891-1897.
29. Walch JM, Lakkis FG. T-cell migration to vascularized organ allografts. Curr Opin Organ Transplant 2014; 19:28-32.
30. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4:1475-1489.
31. Li L, Khush K, Hsieh SC, et al. Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection. PLoS One 2013; 8:e82153.
32. Mas VR, Dumur CI, Scian MJ, et al. MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant 2013; 13:11-19.
33. Khella HW, Bakhet M, Lichner Z, et al. MicroRNAs in kidney disease: an emerging understanding. Am J Kidney Dis 2013; 61:798-808.
34. Scian MJ, Maluf DG, Mas VR. MiRNAs in kidney transplantation: potential role as new biomarkers. Expert Rev Mol Diagn 2013; 13:93-104.
35. Wilflingseder J, Regele H, Perco P, et al. miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation 2013; 95:835-841.